An Open-Label, Phase 1 Study of the Safety Pharmacokinetic Profile, and Preliminary Efficacy, of Organic Whole Psilocybin-Containing Mushrooms in Patients Suffering From PTSD - Suzanne "Sue" Sisley MD (ClinicalTrials.gov, 2026)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com